Dr René Fáber (Photo copyright: Sartorius).
Dr René Fáber (Photo copyright: Sartorius).
Gerry Mackay (Photo copyright: Sartorius).
Gerry Mackay (Photo copyright: Sartorius).
Reinhard Vogt (Photo copyright: Sartorius).
Reinhard Vogt (Photo copyright: Sartorius).

At Sartorius AG, Dr René Fáber, as head of the Bioprocess Solutions Division, and Gerry Mackay, as head of the Lab Products & Services Division, are to join the company’s executive board from 1 January 2019.

Dr Fáber, 43, has been working at Sartorius since 2002. He started as an R&D scientist in the Membrane Modification Department, then headed R&D Process Technologies. Later, as vice president, he held various management positions in marketing for Filtration and Fermentation Technologies, as well as in key account management. He has most recently been responsible for the product development unit of the Bioprocess Solutions Division.

Mackay, 56, joined Sartorius in 2015 with the acquisition of BioOutsource, where he had been CEO since 2009. Prior to his tenure with BioOutsource, he held senior international positions in sales and marketing at a number of companies, including Millipore. Sartorius says that as head of Marketing, Sales and Services for its Lab Products & Services Division, Mackay drove the momentum of the division’s new strategic direction towards the biopharmaceutical market and its respective applications and technologies.

Meanwhile, supervisory board and executive board member Reinhard Vogt will step down from his position on the executive board on 31 December 2018. Vogt has served the company for more than 35 years in various functions and has been a member of the executive board since 2009.

From 1 January 2019, the Sartorius executive board will have four members: Dr Joachim Kreuzburg (chairman and CEO); Dr René Fáber (head of Bioprocess Solutions); Gerry Mackay (head of Lab Products & Services); and Rainer Lehmann (chief financial officer).